Compound Profiles
MK-677
Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue
Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..
Rapamycin
mTOR Inhibitor | Longevity & Immunosuppression
Rapamycin exerts its effects by binding to the intracellular protein FKBP12, forming a complex that directly and specifically inhibits mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 is a master nutrient-sensing kinase that integrates signals from growth factors, amino acids, energy status, and stress to regulate cell growth, proliferation, and metabolism.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take MK-677 with Rapamycin?
Yes, but with caution. Both MK-677 and Rapamycin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.
Is MK-677 and Rapamycin safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between MK-677 and Rapamycin?
Both MK-677 and Rapamycin affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time MK-677 and Rapamycin?
MK-677 has a half-life of ~24 hours and Rapamycin has a half-life of ~62 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.